Physician profile
Joshua Daniel
NPI 1407101439
$2,969.79
in general payments reported to CMS, 2019-2025
21 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $50.00 · 2021: $208 · 2022: $473 · 2023: $734 · 2024: $627 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,790.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $908.96 | 2019-2025 | Argos, Clareon, Rocklatan |
| Abbvie INC. | $475.37 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Sun Pharmaceutical Industries INC. | $391.81 | 2022-2025 | Cequa |
| Bausch & Lomb Americas INC. | $226.46 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $164.37 | 2019-2021 | |
| Coopervision INC. | $139.13 | 2025 | Myday Contact Lens, Clariti Contact Lens |
| Oyster Point Pharma, INC. | $129.57 | 2022-2025 | Tyrvaya, Ryzumvi |
| Shire North American Group INC | $72.90 | 2019 | |
| Sight Sciences, INC. | $71.44 | 2023 | Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $67.34 | 2022-2023 | Acthar |
| Kala Pharmaceuticals, INC. | $58.62 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $46.67 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $35.58 | 2023 | |
| Novartis Pharmaceuticals Corporation | $35.04 | 2021-2023 | |
| Ani Pharmaceuticals, INC. | $31.41 | 2025 | Purified Cortrophin Gel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.61 | 2019 | |
| Dompe US, INC. | $22.37 | 2024 | Oxervate |
| Rxsight INC | $21.64 | 2024 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Allergan, INC. | $18.08 | 2021 | |
| Vyera Pharmaceuticals, LLC | $15.70 | 2019 | |
| Tearlab Corp | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.